{"symbol":"BSX","fiscalQuarter":"Q2-2019","reportDate":"2019-07-24","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q2-2019","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Down 0.02%","keyNumbers":[{"metric":"EPS","actual":"$0.39","expected":"N/A","surprise":"-0.19%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation and product development.","They noted challenges in certain markets but remain focused on long-term growth."],"summary":"Overall, management expressed a cautious optimism about future growth despite current market challenges. They emphasized their commitment to innovation."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a slight miss on EPS, which may indicate some pressure on profitability. The stock reacted minimally, down just 0.02%, suggesting that investors may have anticipated the results. Management's focus on innovation and long-term growth could provide a positive outlook, but the lack of revenue data leaves some uncertainty.","metaDescription":"Boston Scientific (BSX) Q2 2019 earnings: EPS missed. Stock down 0.02%. Full breakdown."}}